INS and type 2 diabetes mellitus: Additionally, although not statistically significant, patients within GDM-miR-330high subgroup retained an higher rate of predisposing T2D genetic background, having at least one first-degree relative affected by T2D and, furthermore, were more likely to require future insulin therapy respect to patients with low miR-330-3p expression (Table 3).